175 related articles for article (PubMed ID: 30014256)
1. Low dosage of arsenic trioxide (As
Luo D; Zhang X; Du R; Gao W; Luo N; Zhao S; Li Y; Chen R; Wang H; Bao Y; Yang W; Liu D; Shen W
J Biol Inorg Chem; 2018 Aug; 23(6):939-947. PubMed ID: 30014256
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells.
Xu Q; Liu Z; Zhu ZQ; Fan Y; Chen R; Xie XH; Cheng M
Bioengineered; 2021 Dec; 12(2):12179-12190. PubMed ID: 34783299
[TBL] [Abstract][Full Text] [Related]
3. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
4. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a.
Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
7. [CircRNA-0028171 regulates arsenic trioxide-induced apoptosis in vascular endothelial cells].
Wu JC; Jin SD; Song JH; Liu XQ; Ma WJ; Chang L; Guan XX; Zhang MY; Liu JQ; Fu H; Wang Y; Xu CQ
Sheng Li Xue Bao; 2022 Oct; 74(5):763-772. PubMed ID: 36319099
[TBL] [Abstract][Full Text] [Related]
8. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.
Xiao YF; Wu DD; Liu SX; Chen X; Ren LF
World J Gastroenterol; 2007 Dec; 13(48):6498-505. PubMed ID: 18161919
[TBL] [Abstract][Full Text] [Related]
9. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
Yang MH; Chang KJ; Li B; Chen WS
Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
Guan J; Darb-Esfahani S; Richter R; Taube ET; Ruscito I; Mahner S; Woelber L; Prieske K; Concin N; Vergote I; Van Nieuwenhuysen E; Achimas-Cadariu P; Glajzer J; Woopen H; Stanske M; Kulbe H; Denkert C; Sehouli J; Braicu EI
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1063-1073. PubMed ID: 30810838
[TBL] [Abstract][Full Text] [Related]
12. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.
Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P
Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321
[TBL] [Abstract][Full Text] [Related]
13. Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis.
Zhang F; Zhang CM; Li S; Wang KK; Guo BB; Fu Y; Liu LY; Zhang Y; Jiang HY; Wu CJ
Mol Med Rep; 2018 Jan; 17(1):1573-1582. PubMed ID: 29138840
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2.
Tu Y; Liu L; Zhao D; Liu Y; Ma X; Fan Y; Wan L; Huang T; Cheng Z; Shen B
Sci Rep; 2015 Sep; 5():13827. PubMed ID: 26345385
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
[TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
Shen K; Ji L; Lu B; Wang Z
Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
[TBL] [Abstract][Full Text] [Related]
18. Targeting Angiogenesis: Taming the Medusa of Ovarian Cancer.
Dhani NC; Oza AM
Hematol Oncol Clin North Am; 2018 Dec; 32(6):1041-1055. PubMed ID: 30390759
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Baicalin on Arsenic Trioxide-induced Oxidative Damage and Apoptosis in Human Umbilical Vein Endothelial Cells.
Tsai CL; Tsai CW; Chang WS; Lin JC; Hsia TC; Bau DT
In Vivo; 2021; 35(1):155-162. PubMed ID: 33402461
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich α-2-glycoprotein-1.
Fan M; Li C; He P; Fu Y; Li M; Zhao X
Anticancer Drugs; 2019 Jul; 30(6):562-570. PubMed ID: 30896502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
